Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Citius Pharmaceuticals Inc (NQ: CTXR )

1.300 USD +0.110 (+9.24%)
Streaming Delayed Price Updated: 2:41 PM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,476,251
Open 1.190
Bid (Size) 1.290 (51)
Ask (Size) 1.300 (29)
Prev. Close 1.190
Today's Range 1.190 - 1.330
52wk Range 0.4100 - 1.970
Shares Outstanding 10,677,222
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Citius Pharmaceuticals to Present Update on Proprietary Product Candidates at Two Virtual Conferences in January
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, today announced that it will be... 
From PR Newswire
Citius Holds Webinar Series on Conducting Mino-Lok Phase 3 Trial During COVID-19
- Infectious Disease experts provide review of CLABSI patient management in a restricted environment 
From PR Newswire

Performance

YTD
+25.00%
+25.00%
1 Month
+14.04%
+14.04%
3 Month
+12.07%
+12.07%
6 Month
-12.75%
-12.75%
1 Year
+27.45%
+27.45%

More News

Read More
Citius Pharmaceuticals Receives FDA Response and Guidance to Pre-IND Consultation Submission for Mino-Wrap
From PR Newswire
How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients
From PR Newswire
Citius Pharmaceuticals Subsidiary NoveCite Announces Data from a Study of Induced Mesenchymal Stem Cell ("i-MSC") Therapy in an in vivo Model of Acute Respiratory Distress Syndrome ("ARDS")
From PR Newswire
Citius Pharmaceuticals to Present Corporate Update at Benzinga Global Small Cap Conference on December 8
From PR Newswire
Citius Announces Results of Study that Mino-Lok Eradicates S. aureus Biofilm More Effectively and Expeditiously than Components
From PR Newswire
Citius Pharmaceuticals to Present at Virtual Fall Investor Summit
From PR Newswire
Citius Pharmaceuticals to Present at H.C. Wainwright 6th Annual Israel Conference
From PR Newswire
Creative Contactless Disinfection Solutions Arise in a Time of Need
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.